Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Oct;24(5):282.e1-282.e7.
doi: 10.1016/j.jaapos.2020.06.009. Epub 2020 Oct 9.

A randomized clinical trial of contrast increment protocols for binocular amblyopia treatment

Affiliations
Randomized Controlled Trial

A randomized clinical trial of contrast increment protocols for binocular amblyopia treatment

Reed M Jost et al. J AAPOS. 2020 Oct.

Abstract

Background: Most clinical trials of contrast-rebalanced binocular amblyopia treatment used a contrast increment protocol of 10% daily with successful play. Paired with a definition of success requiring only 15-30 min/day of gameplay, this increment protocol could allow children to reach 100% fellow eye contrast in 3-9 hours; however, this may not provide adequate therapeutic time with reduced fellow eye contrast. The purpose of this study was to compare the original protocol against three alternative contrast increment protocols designed to increase the number of treatment hours.

Methods: In this prospective study, 63 amblyopic children (4-10 years; amblyopic eye visual acuity, 20/40-125) were randomly assigned one of four daily contrast increment protocols for 4 weeks, all starting with 20% fellow eye contrast: 10%, 5%, 0%, or 10% for first 4 weeks then reset to 20% and repeat 10% increment for the final 4 weeks. Children played contrast-rebalanced games for 1 hour/day, 5 days/week. Best-corrected visual acuity, stereoacuity, and suppression were assessed at baseline and every 2 weeks until the 8-week outcome visit.

Results: At baseline, mean amblyopic eye best-corrected visual acuity was 0.47 ± 0.14 logMAR (20/60), improving overall 0.14 ± 0.08 logMAR (1.4 lines; P < 0.0001) at 8 weeks. All four protocols resulted in similar improvement in visual acuity (0.13-0.16 logMAR; all Ps < 0.0002). Stereoacuity and suppression also improved (all Ps < 0.05).

Conclusions: None of the new protocols resulted in less improvement than the original 10% contrast increment protocol. Contrast-rebalanced binocular games yielded significant improvements in visual acuity, stereoacuity, and suppression with or without daily contrast increments.

Trial registration: ClinicalTrials.gov NCT03288948.

PubMed Disclaimer

Figures

FIG 1.
FIG 1.
Consort diagram showing the number of completed and missed visits during the 8-week study period. There were 5 missed follow-up examinations among the 63 children who completed 8-week visit. There were 5 children, excluded from analysis, lost to follow-up between the baseline visit and the 8-week final examination.
FIG 2.
FIG 2.
Illustration of hypothetical fellow eye contrast percentage for the four contrast increment protocols over the 8-week study.
FIG 3.
FIG 3.
Amblyopic eye best-corrected visual acuity (BCVA) improvement at baseline, 2 weeks, 4 weeks, 6 weeks, and 8 weeks. Error bars represent ± standard error. P values are group differences from baseline.
FIG 4.
FIG 4.
Amblyopic eye best-corrected visual acuity (BCVA) at the baseline and 8 weeks for children with 10% contrast increment, 5%, 0%, and 10% + reset. Data points above the line indicate improvement. Overlapping symbols are slightly shifted for clarity.

References

    1. Friedman DS, Repka MX, Katz J, et al. Prevalence of amblyopia and strabismus in white and African American children aged 6 through 71 months the Baltimore Pediatric Eye Disease Study. Ophthalmology 2009;116:2128–34. - PMC - PubMed
    1. Multi-Ethnic Pediatric Eye Disease Study. Prevalence of amblyopia and strabismus in African American and Hispanic children ages 6 to 72 months the Multi-ethnic Pediatric Eye Disease Study. Ophthalmology 2008;115:1229–36. - PMC - PubMed
    1. Repka MX, Wallace DK, Beck RW, et al., Pediatric Eye Disease Investigator Group. Two-year follow-up of a 6-month randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2005;123:149–57. - PubMed
    1. Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol 2003;121:603–11. - PubMed
    1. Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci 2004;45: 3048–54. - PubMed

Publication types

Associated data